GlassScriptPhysician profile
Rex Lee Harris
NPI 1861804627
$5,071.59
in general payments reported to CMS, 2019-2025
42 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $698 · 2021: $970 · 2022: $1,093 · 2023: $917 · 2024: $334 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,007.85 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $649.41 | 2021-2025 | |
| Amgen INC. | $491.14 | 2019-2024 | Prolia, Evenity |
| Novo Nordisk INC | $481.18 | 2019-2023 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $318.72 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $198.81 | 2022-2024 | Spravato, Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.69 | 2019-2024 | Xifaxan, Trulance |
| Astellas Pharma US INC | $148.46 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.35 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $117.88 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.50 | 2020-2025 | Ofev, Jardiance |
| Abbott Laboratories | $90.84 | 2021-2025 | Freestyle Libre 2, Freestyle Libre |
| Lilly USA, LLC | $83.85 | 2022-2023 | Mounjaro, Jardiance |
| Baxter Healthcare | $78.21 | 2022 | |
| Xeris Pharmaceuticals, INC. | $77.86 | 2022-2023 | Gvoke Hypopen, Keveyis |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.